Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Diabetic Monitoring Analyzers Are Small, Convenient, and Cost-Effective

By LabMedica International staff writers
Posted on 10 Mar 2010
Two analyzers were introduced to meet the growing global demand for improved management of diabetes.

Offering improved outcomes and reducing the healthcare burden, Quo-Test and Quo-Lab were developed to provide simplicity and performance at a low cost per test.

A single drop of blood from a finger prick sample is needed to provide HbA1c results in four minutes using the new analyzers. More...
HbA1C is a specific type of glycated hemoglobin, formed when glucose present in the blood attaches to hemoglobin. Whereas a blood glucose test can only measure what the blood glucose level is at the moment the test is done, an HbA1c test provides a way of assessing the average blood glucose level over the previous 6-8 weeks.

Globally recognized as the gold standard indicator of metabolic control of blood glucose, regular HbA1c monitoring helps minimize the long-term complications of diabetes, improve health outcomes, and reduce the escalating financial burden of the disease.

With full data connectivity and print options the newly introduced instruments deliver precise, accurate results wherever they are needed, in the laboratory or at the point of care (POC).

Quotient Diagnostics (Walton on Thames, UK) introduced the diabetic monitoring analyzers for the first time in the United Arab Emirates (a region where the disease is a major health issue) in January 2010 at the Arab Health exhibition in Dubai (UAE).

Diabetes is a major health issue in The United Arab Emirates, which has the second highest diabetes rate in the world. The disease is at the top of the agenda for the region's health professionals.

Related Links:

Quotient Diagnostics
Arab Health exhibition in Dubai




Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.